Your post again no more than a mishmash of empty assertion. No supportive links. Your presentation itself wouldn't pass grade-school assignment muster. And as far as content goes you don't even mention Dr.Zelenko used hydroxychloroquine in combination with other drugs.
i know you think the NYT is all part of your conspiracy involving millions of hospitals, doctors, nurses, coroners and administrators worldwide (yet not one whistleblower), but that is just part of your blow. Your QAnon bullshit is just that.
How Dr. Vladimir Zelenko’s claims for his coronavirus treatment spread from a New York village all the way to President Trump.
IMAGE - Dr. Vladimir Zelenko near one of his offices, in Monsey, N.Y. Dr. Zelenko has claimed his drug treatment cured hundreds of coronavirus patients. Bryan Derballa for The New York Times
The source was Dr. Vladimir Zelenko, 46, a mild-mannered family doctor with offices near the village. Since early March, his clinics had treated people with coronavirus-like symptoms, and he had developed an experimental treatment consisting of an antimalarial medication called hydroxychloroquine .. https://www.nytimes.com/2020/04/01/health/hydroxychloroquine-coronavirus-malaria.html , the antibiotic azithromycin and zinc sulfate.
After testing this three-drug cocktail on hundreds of patients, some of whom had only mild or moderate symptoms when they arrived, Dr. Zelenko claimed that 100 percent of them had survived the virus with no hospitalizations and no need for a ventilator.
“I’m seeing tremendous positive results,” he said in a March 21 video, which was addressed to President Trump and eventually posted to YouTube and Facebook.
What happened next is a modern pandemic parable that illustrates how the coronavirus is colliding with our fragile information ecosystem: a jumble of facts, falsehoods and viral rumors patched together from Twitter threads and shards of online news, amplified by armchair experts and professional partisans and pumped through the warp-speed accelerator of social media.
Dr. Zelenko’s treatment arrived at a useful moment for Mr. Trump and his media supporters, who have at times appeared more interested in discussing miracle cures than testing delays or ventilator shortages.
Sean Hannity, the Fox News host, quickly promoted Dr. Zelenko’s claims on his TV and radio shows. Mark Meadows, the incoming White House chief of staff, called Dr. Zelenko to ask about his treatment plan. And Rudolph W. Giuliani, Mr. Trump’s personal lawyer, praised him in a podcast interview this week for “thinking of solutions, just like the president.”
Few people have been as hopeful about hydroxychloroquine as Mr. Trump, who has enthusiastically promoted it for weeks as “very effective” and possibly “the biggest game changer in the history of medicine” — even as health experts have cautioned that more research and testing are needed.
That has not deterred Mr. Trump’s supporters, who have vilified public health officials such as Dr. Anthony S. Fauci .. https://www.nytimes.com/2020/03/28/technology/coronavirus-fauci-trump-conspiracy-target.html , the head of the National Institute of Allergy and Infectious Diseases and the most outspoken advocate of emergency virus measures. Instead, some are pinning their hopes on Dr. Zelenko and his unproven treatment plan, which has now been seen by millions.
In a phone interview from his home, where he has been in self-isolation, Dr. Zelenko, who goes by Zev, described a dizzying week filled with calls from media and health officials from countries including Israel, Ukraine and Russia, all seeking information about his treatment. Some world leaders, including Brazil’s president, Jair Bolsonaro .. https://www.nytimes.com/2020/04/01/world/americas/brazil-bolsonaro-coronavirus.html?action=click&module=Top%20Stories&pgtype=Homepage , are also talking up some of the same drugs as a cure.
“It’s a very surreal moment,” said Dr. Zelenko, who has been practicing medicine for 16 years. “I’m a simple country doctor, you know. I don’t have connections.”
[INSERT: So thanks to a misinformation-rush some who need the drug for proven use might have had to go without.]
In New York’s tight-knit Hasidic community, Dr. Zelenko’s sudden fame has caused tensions. Shortly after he posted on YouTube, a group of village officials wrote an open letter .. https://matzav.com/letter-kiryas-joel-responds-to-dr-zev-zelenko/ .. pleading with him to stop. They said he had exaggerated the extent of the coronavirus outbreak in Kiryas Joel, using a small sample of his patients to predict that as many as 90 percent of village residents would get the virus.
“Dr. Zelenko’s videos have caused widespread fear that has resulted in the discrimination against members of the Hasidic community throughout the region,” the officials wrote, disputing the figure.
“Anyone who tells you these drugs work, or don’t work, is not basing that view on science,” said David Juurlink, the head of the division of clinical pharmacology at the University of Toronto. “There’s reason to be optimistic, and there’s also reason to be pessimistic.”
Dr. Jeff Paley, an internist in Englewood, N.J., who shares some patients with Dr. Zelenko, said it was “irresponsible” for him to promote a treatment without warning people that the combination of hydroxychloroquine and azithromycin can cause severe side effects if not properly administered, especially in patients with pre-existing heart problems.
“I’ve gotten numerous calls from patients demanding the regimen, saying they believe Dr. Zelenko is magically curing his patients,” Dr. Paley said.
NOTE Garden Rose, There are two to add to your millions involved in your pandemic hoax. If case you don't have them noted already.
Dr. Zelenko, who learned two years ago that he had a rare form of cancer, was not the first doctor to recommend treating the coronavirus with hydroxychloroquine and azithromycin, though he was among the first to recommend that they be given to patients with only mild symptoms. He said that while he was optimistic, it was too early to tell whether the drugs would ultimately work.
[Note Garden Rose. Do you have evidence Dr. Zelenko has updated that uncertain position of his?]
“It’s a very surreal moment,” Dr. Zelenko said. “I’m a simple country doctor, you know. I don’t have connections.” Bryan Derballa for The New York Times
Dr. Zelenko, who said he supported Mr. Trump, declined to discuss his politics in detail, saying they were “irrelevant” to his medical findings.
“When I see something funny, I maybe in a juvenile way posted it without much thought,” Dr. Zelenko said of the posts. “I never thought that I would be in the public limelight.”
For more than a decade, Dr. Zelenko has been a fixture in Kiryas Joel, where a sign at the village entrance encourages visitors to “dress and behave in a modest way.” Unlike most of the residents, who belong to the Satmar sect of Orthodox Judaism, Dr. Zelenko is part of the Chabad-Lubavitch movement and does not live in Kiryas Joel itself, which has made him something of an outsider.
Ari Felberman, a patient of Dr. Zelenko’s for years, called him a “phenomenal doctor” and said that if he had exaggerated the coronavirus threat in Kiryas Joel, it was only out of concern for his patients’ health.
“When he spoke about how many people were affected, it was just to shake up the community and say, ‘Don’t take this lightly,’” Mr. Felberman said.
[And in posting Hillary Clinton was as dangerous as the virus, was he just trying to shake up the community too?]
Villagers began experiencing coronavirus symptoms in early March. Days later, after Dr. Zelenko began treating patients with his three-drug combination and saw many of them improving, he created a YouTube account and uploaded his video that addressed Mr. Trump.
“At the time, it was a brand-new finding, and I viewed it like a commander in the battlefield,” he said of the video. “I realized I needed to speak to the five-star general.”
Hydroxychloroquine, which is sold under the brand name Plaquenil, has started selling out at many pharmacies nationwide. Some health systems have begun reserving their supplies for coronavirus patients, depriving those who take it for other conditions. At least four states have restricted hydroxychloroquine prescriptions to prevent hoarding .. https://www.nytimes.com/2020/03/24/business/doctors-buying-coronavirus-drugs.html .
HCQ, as hydroxychloroquine is known, is generally considered safe for clinical use. But it can be risky if patients administer the drugs themselves. Last month, an Arizona man died .. https://www.washingtonpost.com/nation/2020/03/24/coronavirus-chloroquine-poisoning-death/ .. after ingesting a type of fish parasite treatment that listed chloroquine phosphate as one of its ingredients.
“You don’t want people stockpiling this at home,” said Dr. Dena Grayson, a biotech executive who has helped develop drugs for Ebola and other epidemics. “If you do get sick, you need to take this under close supervision of a doctor to make sure you don’t drop dead.”
This week, the F.D.A. issued an emergency use authorization .. https://www.nytimes.com/2020/03/19/health/coronavirus-drugs-chloroquine.html .. for hydroxychloroquine and chloroquine, allowing doctors to distribute them to coronavirus patients. The agency’s chief scientist, Denise Hinton, wrote in the authorization order that the drugs “may be effective in treating Covid-19.” New York also recently began clinical trials of hydroxychloroquine combined with azithromycin.
While dealing with his newfound fame, Dr. Zelenko, who has been practicing telemedicine from his home office, is working to keep his coronavirus patients alive. He said his team had seen about 900 patients with possible coronavirus symptoms, treating about 350 with his regimen. None had died as of Thursday, he said, though six were hospitalized and two were on ventilators.
He is worried about his own health. One of his lungs was removed as part of his cancer treatment, and chemotherapy has weakened his immune system, putting him in a high-risk category for the coronavirus.
“I have eight children, and I want to live,” he said. “I’m personally motivated to find a solution.”
Dr. Zelenko said he understood the need for clinical trials but added that ignoring a hopeful possibility was also risky.
“I’m a strong supporter of clinical trials,” he said. “But they take time, and that’s one thing we don’t have. The virus is here, it’s World War III, and not everyone has fully comprehended that yet.”
Ben Decker and Alain Delaquérière contributed research.
Kevin Roose is a columnist for Business Day and a writer-at-large for The New York Times Magazine. His column, “The Shift,” examines the intersection of technology, business, and culture. @kevinroose • Facebook
Matthew Rosenberg, a Washington-based correspondent, was part of a team that won a Pulitzer Prize in 2018 for reporting on Donald Trump and Russia. He previously spent 15 years as a foreign correspondent in Asia, Africa and the Middle East. @AllMattNYT • Facebook
What to know about a pro-ivermectin group’s study touting the drug versus COVID-19
"SKY NEWS Australia disgrace - Sky News Australia banned from YouTube for seven days over Covid misinformation"
Serious conflicts of interest does not bode well for good science.
Drugs Public Health Facebook Fact-checks Coronavirus
A COVID-19 vaccination is administered at a 24-hour, walk-up clinic hosted by the Black Doctors COVID-19 Consortium at Temple University in Philadelphia. (AP)
* A study — actually a review of trials done with ivermectin on COVID-19 patients — claims large reductions in COVID-19 deaths are “possible using ivermectin.”
* The study was done by researchers affiliated with a group that is campaigning for ivermectin to be approved for COVID-19 use, and they did not declare that affiliation in their study. Experts said ivermectin trials on which the review is based were not high quality.
* The FDA warns against taking ivermectin to prevent or treat COVID-19.
Is the anti-parasitic drug ivermectin a "cure" for COVID-19?
We’ve rated False claims such as "mountains of data" show ivermectin "basically obliterates" COVID-19 transmission. Some limited studies suggested that ivermectin can help treat COVID-19; others show no significant impact. Many of the studies had small sample sizes and other limitations.
At the same time, ivermectin has not been universally dismissed as a potential treatment.
A new study has reignited the debate, making claims about fewer coronavirus deaths even though public health authorities say more research is needed.
"New study links ivermectin to ‘large reductions’ in COVID-19 deaths," reads one headline on the Epoch Times.
The headline exaggerates, given that the study says only that fewer deaths might be possible. It is a review of trials done with ivermectin on COVID-19 patients.
Moreover, the study was done by researchers affiliated with a group that is campaigning for ivermectin to be approved for COVID-19 use. Despite their connection to the group, the authors declared in the study they had no conflict of interest.
The World Health Organization, in its COVID-19 treatment guidelines, says: "We recommend not to use ivermectin in patients with COVID-19 except in the context of a clinical trial," citing "very low certainty evidence" about the drug.
The U.S. Food and Drug Administration says ivermectin should not be used to prevent or treat COVID-19. Ivermectin, which is FDA-approved to treat conditions caused by parasitic worms and parasites such as lice, in large doses "is dangerous and can cause serious harm."
Here’s what we know about the study generating favorable headlines of the drug as a way to prevent or treat COVID-19.
The researchers said they analyzed results from studies and looked at mortality rates among people who were given ivermectin versus people who weren’t. The researchers concluded:
"Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally."
They added: "Health professionals should strongly consider its use, in both treatment and" prevention.
Study’s underpinnings
Experts said the trials that the study relies on are not high quality.
Dr. Amesh Adalja, a senior scholar at the Johns Hopkins University Center for Health Security, said the study is a meta-analysis (an analysis of other analyses) "whose strength is dependent on the underlying studies that comprise it."
"In general, most of the ivermectin studies that purport to show a positive benefit are of low quality and have potential sources of bias," which is why the drug is not recommended by the National Institutes of Health or the Infectious Diseases Society of America, he said. "It is only with rigorously designed randomized control trials that any true benefit can be discovered."
Assuming the meta-analysis is correct, ivermectin "would seem to merit further study," said Stephen Morse, an epidemiology professor at Columbia University Medical Center.
Some drugs initially seem promising, but don’t hold up in more rigorous clinical testing, Morse said. For instance, some insisted that hydroxychloroquine was "a cure," but there hasn’t been strong supporting data for it, he said.
"That can be a real problem, and raise unrealistic expectations for a drug that might be very promising or useful, but not a homerun," Morse said.
"Pooling data from a large number of small, low-quality clinical trials does not magically create one large, high-quality clinical trial," wrote Gorski, who is also managing editor of Science-Based Medicine, a website that evaluates .. https://sciencebasedmedicine.org/editorial-staff/ .. medical claims.
He added: "The few existing higher quality clinical trials testing ivermectin against the disease uniformly have failed to find a positive result. It’s only the smaller, lower-quality trials that have been positive. This is a good indication that the drug probably doesn’t work."
Gorski also pointed out that the researchers, despite claiming to have no conflicts of interest, are affiliated with BIRD (British Ivermectin Recommendation Development) Group.
BIRD describes itself as "campaigning for the safe medicine ivermectin to be approved to prevent and cure COVID-19 around the world."
Tess Lawrie, who is one of the study’s co-authors and a BIRD leader, told PolitiFact in an email that her study "shows that large reductions in deaths from COVID are probable when ivermectin is used, especially when employed as early treatment."
That study was led by a University of Connecticut researcher and appeared in the peer-reviewed journal Clinical Infectious Diseases, a publication of the Infectious Diseases Society of America. It found that in comparison to standard of care or placebo, ivermectin "did not reduce all-cause mortality." The study concluded saying that the drug "is not a viable option to treat COVID-19 patients."
BIRD reacted by calling on the journal to take down the meta-analysis or issue a warning about its "incorrect information."
Our Sources
Epoch Times, "New Study Links Ivermectin to ‘Large Reductions’ in COVID-19 Deaths," June 21, 2021
American Journal of Therapeutics, "Ivermectin for Prevention and Treatment of COVID-19 Infection," June 17, 2021
Science-Based Medicine, "Ivermectin is the new hydroxychloroquine, take 2," June 21, 2021
BIRD Group, home page, accessed June 28, 2021
BIRD Group, "Ivermectin for prevention and treatment of covid-19," Feb. 27, 2021
BIRD Group, "The BIRD Recommendation on the Use of Ivermectin for Covid-19," accessed June 28, 2021
BIRD Group, "Who are the BIRD Group?", accessed June 28, 2021
Email, BIRD Group leader Tess Lawrie, June 30, 2021
Email, Dr. David Gorski, a professor of surgery and oncology at Wayne State University, chief of breast surgery at the Karmanos Cancer Institute and managing editor of Science-Based Medicine, June 28, 2021
Email, Dr. Amesh Adalja, senior scholar, Johns Hopkins University Center for Health Security, June 28, 2021
Email, Stephen Morse, epidemiology professor at Columbia University Medical Center and director of the Infectious Disease Epidemiology Certificate Program, June 28, 2021
Market Data 
Markets 
AI
